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Abstract: (1) Background: The harm of misusing over-the-counter (OTC) codeine-containing
medicines among university students in England is being increasingly recognized. Based on English
university students, this paper aims to study the importance of information design on information
communication, explore methods for effective warning design, and investigate university students’
perception of OTC codeine. (2) Methods: The effective warning design is addressed through
case studies, answering correctness by the heat map generated from the eye-tracking experiment
(ETE), and the total time spent on the tasks. User perceptions are made though online surveys.
(3) Results: Information design significantly affects the way user processes information. Therefore,
two emphasized warnings displayed in the headline, and the “possible side effect (PSE)” sections
and warning signs of addiction presented under the PSE are suggested as effective ways to display
warnings. For students’ perception of OTC codeine, 80% of university students are unfamiliar
with the substance. After reading the patient information leaflets (PILs), 47% recommended tight
regulation on codeine. (4) Conclusions: The misuse of OTC codeine could be a potential problem
among English university students. The design of the PIL significantly influences the chance of
unintentional medicine misuse. The display of warnings on the PILs of OTC codeine should be
redesigned for better understanding.
Keywords: patient education; medication management and safety; university students; codeine;
patient information leaflet; over the counter
1. Introduction
With the potential harm of over-the-counter (OTC) codeine being increasingly acknowledged,
a regulation on OTC codeine-containing analgesics was implemented in 2014. A warning term “Can
cause addiction. For three days use only” and the warning signs of addiction were mandatory for
every patient information leaflet (PIL) of OTC codeine-containing analgesics. However, without a
further indication of where and how to display warnings about addiction, the effects of this regulation
remain uncertain and limited [1,2].
OTCmedicine is usually considered safe to use and available for self-medication [1,3]. Even though
OTC medicines are comparably safe and mild in effects, the misuse of medicine, which was proven not
rare in the UK, can still lead to severe consequences such as addiction and fatality [4–6]. This situation
has raised concern since medicines such as OTC codeine, the most widely used opioid medicine,
is very likely to cause harm [7–9]. Codeine, an opioid pain reliever, is available on prescription, or in
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lower-strength OTC medicines as a companion to other ingredients such as ibuprofen, caffeine, and
paracetamol since it is useful in extending the duration of effects [10–14]. However, the misuse and
abuse of OTC codeine-containing medicines can lead to not only addiction caused by codeine but can
also lead to renal and liver damage caused by ibuprofen and paracetamol [11,15–18]. Besides, the
consumption of codeine could lead to long-term use and dependence on opioids or other addictive
substances such as heroin [5,8,19–22].
Codeine misuse and abuse are potentially harmful to individuals, societies, and the economy.
Codeine misuse can be especially problematic for the United Kingdom since 44.2 tons of codeine was
consumed in the UK in 2016, which was the second-biggest consumer of codeine in the world [21,23].
Among all English nationals, university students are at high risk of misusing OTC codeine, since
the university students were proven more likely to misuse and abuse medicines compared to other
adults [24,25]. However, insufficient attention was paid to drug intervention of English university
students [26].
With increasing awareness of the severe outcomes of codeine misuse, interventions on the
production and sale of codeine-containing medicines, including direct pharmacy intervention and
online monitoring have been proposed and adopted in England [14]. However, it has been shown that
a majority of people in England were not fully aware of the potential risks when they started using
codeine-containing medicines [14,16,26]. Therefore, more efforts on patient education is needed, since
patient education is effective in preventing medicine misuse [26–32].
For patient education, patient information leaflets (PILs) (a package insert that is mandatory for
all medications sold in England) was rated the most reliable and essential source of side effects of
medication [33,34]. Accordingly, a tightened regulation on the PIL of OTC codeine was published
by the UK government in 2014 [35,36]. The term “Can cause addiction. For three days use only”
and an indication on the signs of addiction is demanded for every PIL [2]. However, without
further indications of where and how to display this information, the effects of this regulation remain
unknown and are potentially limited. Under the circumstances where information design is found
influential to the accuracy and amount of information acquired by readers, the investigation on the
displacement of warnings about addiction is crucial for increasing public awareness and decreasing
codeine misuse [37–39].
Therefore, utilizing a sample from English university students, the aims of the research were:
(1) to investigate how essential the information design is for effective communication, (2) to identify
an effective way to display warnings about addiction on the PILs of OTC codeine, and (3) to study
English students’ attitudes and perceptions of OTC codeine-containing medicines.
To achieve these research aims, the research started with two case studies, one offline and one
online, to assess the availability of OTC codeine among English university students and collect samples
for the following experiment. Then an eye-tracking experiment along with a pre-experimental online
survey and a post-experimental online survey was used to identify students’ perception of OTC
codeine, the impact of information design on eye-movement, and effective ways of displaying warning
terms. Two samples with similar word count, template, and efficacy but with different ways of
displaying warnings were chosen for the eye-tracking experiment. Thus, the independent variables
are the displayed location of warning information and appeared frequency of occurrence, and the
dependent variables are participants’ reaction time and accuracy of finding several specific warning
terms and attention locations. One sample was expected to establish a feasible standard for warning
design, based on the understanding of information design principles [40–43]. We hypothesized that
frequently appeared and highlighted information is more accessible for readers to recognize. With a
systematic analysis of the research data and findings, this paper will conclude with answers to three
research aims and the hypothesis proposed in the sample selection.
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2. Materials and Methods
Three experimentalmethodswere adopted. Two rounds of case studies onOTC codeine-containing
medicines that are on sale were conducted to develop a better understanding of existing warning
designs of addiction on the PILs. An eye-tracking experiment, which measures readers’ horizontal
gaze nystagmus, was conducted to study how the information affects mental functioning. Finally,
surveys about personal information and the perception of OTC codeine was conducted before and
after the eye-tracking experiment.
2.1. Case Study
In the first round of case studies, PILs of 46 OTC medicines available in England were collected
in hard copies from 16 English volunteer students at the University of Leeds. Among the PILS
collected, 16 were PILs of OTC analgesics. Five of OTC analgesics contained codeine as one of the
active ingredients, namely, Syndol Tables from SANOFI, Solpadeine Plus from Omega Pharma Ltd.,
Paramol Tablets from Reckitt Benckiser Healthcare Ltd., Co-damol Tablets from Accord, and Co-damol
Effervescent Tablets from Zentiva.
Then, in the second round of case studies, more PILs of OTC codeine-containing medicines
were collected online through the electronic medicines compendium (EMC), which is a website that
offers more than 14,000 documents of medicines licensed for use in England [44]. The other 14 active
PILs of codeine-containing medicines were found. The PILs would be investigated in terms of target
symptoms, word count, structural layout, and placement of warning signs of addiction.
2.2. Eye-Tracking Experiment and Survey
2.2.1. Sample Selection
For the eye-tracking experiment, two samples with different places and ways to display warning
signs were selected from PILs of OTC codeine collected in the case studies. Based on our understanding
of information design principles, one was expected to establish a feasible standard of information
placement in comparison to another sample. In order to minimize the variance from wording
and template, the selected samples were similar in word count, text column number, and efficacy.
In accordance with these criteria, two PILs with a two-column layout, the PILs of Solpadeine Plus from
Omega pharma Ltd. and Codeine Phosphate from Thronton & rose Ltd., were selected as Sample 1
and Sample 2, respectively. Based on information design principles [40–43], we hypothesized that the
more frequently the information is mentioned, the more accessible the information is to find, and the
terms highlighted in color or icons are more legible than using bolded words, followed by bolded
sentences and then non-bolded sentences. Therefore, Sample 1 was assumed to establish a feasible
standard for the way of displaying warning signs of addiction. Meanwhile, Solpadine Plus was also
identified as the most common licensed OTC codeine in Europe [45].
2.2.2. Questions in the Experiment
A pre-experimental survey was used to collect the user’s personal information and perception
toward OTC codeine. Besides closed questions about age, gender, nationality, and the hometown
of participants, two open-ended questions were designed to investigate participants’ perception of
codeine-containing medicines.
Then, six tasks were taken by participants at the beginning of the eye-tracking experiment.
Participants were asked to find task-related information on the leaflets. The first three questions
required them to find information on target symptoms, dosage, and side-effects of the medicine,
which were proven to be the most prominent information of a PIL [46]. The next three questions asked
participants to identify why the medicine is only for a short-time use, the signs of addiction, and the
frequency of mentioning the warning sign of addiction in the sample.
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At last, a questionnaire for the follow-up survey was created to identify participants’ attitudes
towardOTC codeine-containingmedicines, and their perception of design. Therewere four open-ended
questions and one question was asked twice, both at the beginning and the end of the experiment.
In total, 16 questions were used throughout the experiment, which are summarized in Table 1.
Table 1. Questions asked before, during, and after the eye-tracking experiment.
Questions asked before the eye-tracking experiment:
Question 1: How old are you?
Question 2: Which gender do you identify yourself as?
Question 3: What is your nationality?
Question 4: Where is your home town?
Question 5: Are you familiar with opioid analgesic or codeine-containing medicines?
Question 6: In what situation do you tend to buy over-the-counter codeine containing medicines?
Questions asked during the eye-tracking experiment:
Task 1: Please identify what symptoms that this medicine is intended to treat.
Task 2: Please identify the maximum dosage for this medicine (dosage per day; maximum days).
Task 3: Please identify the side effects of this medicine.
Task 4: Please identify the reason why this medicine is only for short-time treatment.
Task 5: How do you know if you are addicted?
Task 6: Please identify how many times the warning sign of addiction was mentioned in this leaflet.
Questions asked after the eye-tracking experiment:
Question 1: In what situation do you tend to buy over-the-counter codeine containing medicines?
Question 2: How do you think of the availability and regulation of over-the-counter codeine?
Question 3: Have you seen these two patient information leaflets before?
Question 4: Which patient information leaflet is more helpful to you? Why?
2.2.3. Participant Recruitment
In order to ensure similar cultural backgrounds and proficiency in English, we recruited
30 registered university students at the University of Leeds with English ethnicity and no specific
restrictions on their major. The gender of the participants needed to be balanced since gender was
relevant to substance abuse [47]. The participants were recruited online through an email written by the
researcher and sent by the reception of the University of Leeds. This email contained the introduction
of research background and objectives, the information of time and location, the target participants for
the eye-tracking experiment and online surveys, and a link to a booking website (youcanbookme.com)
which allowed the qualified participants to each select and book an experiment session online. In total,
30 qualified participants were recruited for the experiment. Participant recruitment and experiments
took place from November to December 2019.
2.2.4. Testing Procedure
The experiment was conducted using an eye-tracking device to record each participant’s eye
movements for each sample. Researchers waited in the room ahead of the reserved session, with
information sheets and consent forms prepared and printed out. As participants arrived, they were
each introduced individually to the background, aim, and potential risks of the study through an
information sheet and oral explanation by the researchers. The consent forms were then presented and
signed before the commencing of the experiment.
For the implementation of the experiment, each participant was scheduled a maximum of one
hour to finish a questionnaire, an eye-tracking experiment, and a follow-up survey. Once completing
the pre-experimental survey, the eye-tracking experiment could be implemented. During the test, each
participant was presented with the two samples in random order; that is, every 15 participants would
be presented with samples in the same order. During the experiment, the participants were first given
about 30 s to look at the sample before the tasks were introduced. Then the six different tasks of each
sample were presented to the participants on the screen by order. They were asked to write down
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answers to each task on paper. However, participants were not allowed to go back to check answers
and were instructed not to go back to check answers or write down answers based on their knowledge.
This process was conducted again for the sample presented in the second order.
After completing the eye-tracking experiment, a follow-up survey was displayed online using
Google Forms. Participants were asked to complete the questionnaire by themselves. Intervention and
assistance from the researcher were only given when questions or concerns were bought up by the
participants. Each participant was given five English pounds at the end of their session as thanks for
their time and contribution.
2.2.5. Data Collection and Analysis
The information collected from the case study was organized and analyzed by using SPSS (IBM,
Armonk, NY, USA) statistics. As for the results of the eye-tracking experiment and online survey, all
research data would be retained in the digital format. The results of the eye-tracking experiment were
displayed in heat maps; the influence of information design on the effectiveness of the PIL would be
measured based on the overlap of the correct answer and color-coded areas, the color-coded areas that
did not contain the correct answer, and the sum of time to find information for all the tasks.
2.2.6. Ethical Consideration
This research complied with the American Psychological Association Code of Ethics and was
approved by the Institutional Review Board at the University of Leeds (LTDESN-116).
3. Results
3.1. Case Study
Five out of 46 PILs collected in the first round of case studies were codeine-containing medicines.
They were offered by five different volunteers. Then, 14 leaflets of codeine-containing medicines (with
10 for pain relief, three for dry cough, and one for cold & flu) were found on the EMC by researching the
keyword, “codeine,” within the category of OTC medicines. Therefore, 19 PILs of codeine-containing
OTC medicines were found for further investigation. As shown in Table 2, the 19 PILs were grouped
by efficacy and listed in alphabetic order. They were each analyzed in terms of text layout, word
count, visual elements, and print size. As seen in Table 2, 78% of codeine-containing medicines were
designed to treat pain. The content of codeine per pack varies with the name of medicines and pack
size available on the market. As for the design of the PILs, 68% of medicines were designed with a
two-column structure layout, and the warnings about addiction were not colored or did not accompany
an icon in 63% of the PILs.
Int. J. Environ. Res. Public Health 2020, 17, 5490 6 of 17
Table 2. Analysis of the patient information leaflets (PILs) of over-the-counter (OTC) codeine containing medicines collected for case studies.
No Medicine Efficacy Text Column Word Count Icons & Colour Print Size/cm
1 Co-damol Tablets (Accord) Pain 2 1659 None 21.0 × 29.6
2 Co-damol Tablets (M&A Pharmachem Ltd.) Pain 2 2189 None 12.4 × 20.7
3 Co-damol Effervescent Tablets (Zentiva) Pain 1 3020 None 20.9 × 50.0
4 Codeine Phosphate (Thornton & rose Ltd.) Pain 2 2068 None 21.0 × 29.7
5 Codis 500 (Reckitt Benckiser Healthcare UK Ltd.) Pain 2 1788 None 24.1 × 48.2
6 Migraleve Film-coated Tablets (McNeil Products) Pain 3 2478 Both 25.0 × 14.5
7 Nurofen Plus (Reckitt Benckiser Healthcare Ltd.) Pain 2 4914 None 19.2 × 29.6
8 Panadol Ultra Tablets (GlaxoSmithKline Healthcare) Pain 2 2152 Icon 14.1 × 10.6
9 Paramol Tablets (Reckitt Benckiser Healthcare Ltd.) Pain 2 1839 None 18.0 × 26.7
10 Paracetamol, Codeine & Caffeine (Fannin Limited) Pain 2 1717 None 29.7 × 23.8
11 Paracodol Tablets (Delpharm Gaillard) Pain 2 1468 Icon 15.0 × 25.0
12 Solpadeine Plus (Omega pharma Ltd.) Pain 2 1936 Icon 15.0 × 30.5
13 Syndol Headache Relief Tablets (SANOFI) Pain 2 1894 None 21.0 × 28.0
14 Syndol Film-Coated Tablets (SANOFI) Pain 2 2897 None 19.0 × 29.7
15 Veganin (Omega Pharma Ltd.) Pain 2 2482 Colour 14.0 × 22.9
16 Pulmo Bally (DDD Limited) Cold & flu 3 1048 None 16.5 × 12.0
17 Codeine Linctus (Thronton & rose Ltd.) Dry cough 3 1196 Icon 17.0 × 6.49
18 Codeine Linctus BP (Pinewood Laboratories Ltd.) Dry cough 1 1320 None 21.0 × 29.7
19 Galcodine Linctus (Thronton & Ross Ltd.) Dry cough 4 1300 Icon 21.0 × 29.7
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Theways to present awarning about addictionwere investigated in detail. Fourways of displaying
warnings about addiction were identified in four sections of the PILs. In Table 3, with the use of a heat
map, four kinds of warning signs were presented in four different colors and were distributed in four
rows, each row symbolizing a section of information on the PIL. As seen from Table 3, the warning
terms and signs of addiction were presented in all codeine-containing analgesics, either highlighted or
unhighlighted. However, for medicines targeting on cold and flu and dry cough, only one of them
contained a warning about addiction.
Table 3. Investigating the presentation for warnings of addiction.
Presenting Warnings of Addiction 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Headline section
“Before use” section
“How to take” section
“Side-effect” section:
(“How do I know if I am addicted”)
Labeled with color or icon:
Labeled in bolded words:
Labeled in bolded sentences:
Labeled:
Unlisted:
Based on the criteria for sample selection discussed earlier in the Section 2.2.1., two PILs with
similar layout, word count, and efficacy but with a different way of displaying warnings about codeine
were selected for further testing. As seen from Tables 2 and 3, leaflet number 4 and 12 shared similar
layout, word count, and efficacy, but most different way of displaying warnings of addiction. Therefore,
the PILs of Solpadeine Plus from Omega pharma Ltd. and Codeine Phosphate from Thornton & rose
Ltd. were selected as Sample 1 (Figure 1) and Sample 2 (Figure 2) [48,49], respectively.
Figure 1. Sample 1 [48].
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Figure 2. Sample 2 [49].
3.2. Eye-Tracking Experiment
3.2.1. Participants’ Information and Their Perception of OTC Codeine
Among the 30 participants of the eye-tracking experiment, 15 were female and 15 were male.
Twenty-three participants were between the age of 20–30, the other seven were 30–40. All the recruited
participants were English nationals, and five of them mentioned they were immigrants to England.
English was the first language of 25 participants. The results for participants’ familiarity and attitudes
toward OTC codeine are summarized in Figure 3. Twenty-seven percent of them tend to purchase
codeine-containing medicines when feeling sick and merely 3% chose never to purchase it. Eighty
percent of them were unfamiliar with codeine.

(a) (b) 
Figure 3. The results of two questions from the pre-experimental survey: (a) Are you familiar with
opioid analgesic or codeine-containing medicines? (b) Please identify how many times the warning
sign of addiction was mentioned in this leaflet.
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3.2.2. Testing Results
For the eye-tracking experiment of two previously selected samples, the six tasks of each sample
were introduced to each participant during the experiment. The results of the eye-tracking experiment
were summarized in Figures 4–6 using heat-maps. Figures 4–6 presented participants’ initial focus
of the sample, the eye movement, and the coverage of eyesight throughout the whole experiment,
respectively. The field of view was colored in the heat-map. The warmer the color gets, the better the
attention was gained in the section. The correct answers for each task are boxed in the figures.
As shown in Figure 4, information placed on the upper left corner of a PIL was most likely to be
observed in the first 30 s of glances.
čBĎ 	C
 	D
 	E

Figure 4. The result of the eye-tracking experiment for the first 30 s (shown by heat-map images); the
warmer the color gets, the more the attention was gained in the section. (a) The field of view while
looking at sample 1; (b) sample 1; (c) the fields of view while looking at sample 2; (d) sample 2.
Participants’ eye movements while doing six tasks are presented in Figure 5. For the first three
tasks, participants tended to rely on the headline section, especially when there was a headline section
that contained a summary of the information. Then for the fourth question on the reasons for short-time
treatment, readers of Sample 1 were capable of finding the answers in two sections. The majority
of them primarily found the information under the sub-heading, “warning and precaution” in bold
font, while others found the information in the headline section. For Sample 2, even though the
readers eventually found the information, the majority of them skimmed all over the places to seek
information. In task 5, the signs of addiction were asked. This information was displayed twice in
Sample 1 and once in Sample 2, respectively. Nearly all readers of Sample 1 identified the information
in the sub-section called “How do I know if I am addicted?”, which was highlighted and labelled with
an icon. For that of Sample 2, when the information was hidden in the “possible side effect” section,
it seemed that the participants lost focus. For task 6 which asked about the frequency of displaying
warnings about addiction in each sample, the result indicated that readers were capable of finding the
warnings on multiple sections of Sample 1, while only one warning was found in Sample 2 by the
majority of participants.
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Figure 5. Field of view: the result of the eye-tracking experiment (shown by heat-map images); the
left side is Sample 1 and the right side is Sample 2. The correct answers for each task are boxed in
the figures.
For the field of view presented in Figure 6, the intense color occupied 4.68% and 7.85% of the area
in Sample 1 and Sample 2, respectively. Among the intensely colored area, 38.5% of the area in Sample
1 and 57.5% of the area on Sample 2 remained unboxed, which means the readers of Sample 2 spent
more time on ineffective information than those of Sample 1.
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Figure 6. Field of view for all six tasks, the left side is sample 1 and the right side is sample 2. The
correct answers for each task are boxed in the figures.
Then, the total time used by each participant to find correct answers to the tasks was measured
and summarized in Figure 7. The average time spent on Sample 1 was 9.1 min, and that on Sample
2 was 10.9 min. The p-value was calculated as 0.029. Therefore, information design could influence
readers’ speed of finding information. In general, participants found information more quickly using
Sample 1 than using Sample 2.
Figure 7. The time for each participant to find answers for all tasks by using different samples. Only four
participants which are marked by a black box spent a longer time on sample 1 than sample 2.
3.3. Interview
As shown in Figure 8, after being informed with the addictive risk of OTC codeine, 27% of
participants said they would never buy codeine-containing medicines; 55% of participants were likely
to purchase OTC codeine-containing medicines in the future, and six percent of them would only
consume codeine-containing medicine if it was prescribed. For the availability and regulation of OTC
codeine, 28% of the participants were unfamiliar with the regulation and danger; 47% participants
argued that there should be tight restrictions on the regulation and availability since it had the potential
for addiction, and 25% of them found that regulation and availability of OTC codeine was appropriate
enough. None of the participants had seen Sample 1 and 2 before the eye-tracking experiment.
Their preference for both samples was summarized in Table 4.
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Figure 8. The results of two questions from a follow-up survey. From the left to the right: (a) In what
situation do you tend to buy codeine-containing medicines? (b) How do you think of the availability
and regulation of codeine? (c) Have you seen these two patient information leaflets before?
For participants’ preference of sample PILs summarized in Table 4, Sample 1 and 2 were both
favored by 50% of readers. However, the feedback from the participants indicated that Sample 2 was
mostly favored for its overall layout, while Sample 1 was preferred for its clear heading, summarization
of information in the headline section, and clear and repeated warning on addiction.
Table 4. Answers to the question “Which PIL is more helpful to you?”.
Frequency Feedbacks Frequency
Sample 1 15
I felt that I could find things easier in sample 1 2
Clear layout, clear heading, clear warning, summarized the important
information at the top of the sheet.
4
Easier to find the issue as they had a bold format. Address issues more. 2
The structure of the pamphlet, notable the subheadings and bullet points. 1
All the primary information was right at the start of the leaflet which you
immediately go toward. The other one you have to hunt for the information.
1
Clear to read, and the font was larger. It is easy to find what you needed with
subheading in comparison to the second.
2
It was clearer in pointing out the addictive property of codeine, which is very
important and the information was grouped together well within the subtitles.
1
Sample 1 had more information about addiction, and it was clearly laid out. 2
Sample 2 15
The categories are divided better into sections. 1
The layout and typeface are more legible than Sample 1. 8
It was easier to read. Sample 1 had too much bold lettering. 1
This one is easier to read. The information on Sample 1 is all over the place. 1
The headings are more descriptive of each section. 2
It has more subheadings than Sample 1. 1
Sample 1 had too much information; the font size is too small to read. 1
4. Discussion
With a particular focus on English university students, this research aimed to explore the effect of
information design on readers’ eye movement, ability to identify a legible warning design for the PIL,
and to investigate university students’ perception of OTC codeine. Responding to the first research
aim, the result proved that different ways and places of displaying a warning about addiction on the
PIL significantly affected readers’ eye movement. Legible warning designs could speed up the time
readers spent searching for information, thus promoting patient education and reducing unintentional
medicine misuse [30,39,50,51]. For the hypothesis about warning design made prior to the experiment,
the results showed that university students tend to read from the upper left and identify risk factors in
the “possible side effect (PSE)” section, but minor differences were identified on how different formats
of the highlight influenced their eye movement. Therefore, the proposed hypothesis was only partially
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correct. For the second research aim based on the research results, it is suggested that in order to
achieve effective communication of warning, two distinctively highlighted warning terms should be
displayed in both the headline section and the “possible side effect” section, and the warning signs of
addiction should be placed in a separate sub-section under the “possible side effect” section. Then for
the last research aim, which was about students’ perception of OTC codeine, a majority of English
university students were unfamiliar with the risk of codeine. After acknowledging the risks of codeine
through reading the PILs, 47% of them suggested tight regulations on OTC codeine, and 55% of them
may purchase it in the future.
With the influence of information design to the effective communication of information being
approved [38,46,52], findings of this research added credit to previous researches by using results of
the eye-tracking experiment to present English university students’ ways of reading information on the
PIL. Since information design was necessary for patient education [30], the effective presentations of
warning about addiction were aimed to be identified in this research. For the navigation method, the
result suggested that most readers tend to start reading the information from the upper-left corner. This
finding proved the usefulness of the headline section; however, this result contradicted that of Dolk et
al. [53]. When the information process model was identified by Lonsdale [54], the result suggested
that people are more likely to scan (read the information thoroughly from up to down and left to
right) the PILs that have a headline section which contained a summary of relevant information and
skim (purposefully search for content) the PILs which were without such section. For the risk-related
information, participants were more likely to search within the headline section that contained a
summary of relevant information, and the “possible side effect” section. Therefore, the term, “Can
cause addiction. For three days use only” displayed clearly both at the upper-left corner and in the
“possible side effect” section of a PIL is the minimum requirement of the effective communication. For
the signs of addiction, the result suggested that the best practice was to include the information in a
highlighted sub-section under the “possible side effect” section. This finding is meaningful since the
easiness to read is relevant to patient education and users’ willingness to read [55]. However, if this is
used as the standard, then only 21% of collected PILs of OTC codeine met the criterion.
Apart from the results of the eye-tracking experiment, changes in students’ perception toward
codeine also indicated the significance of a legible PIL. According to the findings, students became
more conservative about codeine consumption because of education about codeine, as the rejection rate
on codeine consumption raised from three percent to 27%. In total, 80% of participants were unfamiliar
with codeine, demonstrating the importance of the warnings about addiction for patient education,
especially for first-time users [13]. However, relevant warnings were not found in 15.7% of the recruited
PILs of OTC codeine, especially for those not aimed at treating pain. This finding can be worrying
since codeine was found in PILs of OTC analgesics offered by 31.3% of volunteers. Current regulations
on warning signs of codeine-containing medicines are also actionable for OTC codeine-containing
analgesics. Similar regulations may be applied to OTC codeine that treats other symptoms, such as
dry cough, cold, and flu. Besides, another worrying finding was that half of the participants retained
the possibility to consume OTC codeine in the future even though they were informed of the risk of
codeine. This could be the reason for banning OTC opioids, which was suggested in previous studies
and implemented in Australia in 2018 [56,57].
Limitations
It should be acknowledged that this study was limited in several aspects. Firstly, the result could
be potentially limited by the sampling strategy since the participants were only recruited within the
University of Leeds. Secondly, the effect of the recommended ways of presenting the information could
be influenced by multiple factors once it is applied in practice, such as literacy levels, co-morbidities,
familiarity levels, and different design elements used in each PIL [58–62]. Thirdly, while this study only
discussed the way of displaying warnings on the PIL with a two-column layout for health students,
it might be essential to further prove the suggested way of displaying warning terms again by focusing
Int. J. Environ. Res. Public Health 2020, 17, 5490 14 of 17
on the PILs with a different design. Lastly, since better pain relief is one of the reasons for medication
misuse [5], conducting the experiment again by testing patients who might benefit from OTC codeine
could be another way to further verify the results.
5. Conclusions
In order to prevent OTC codeine misuse, this research proposed a more specified way to present
warnings of addiction. It is suggested that there should be at least two highlighted terms, “Can cause
addiction. For three days use only,” displaying separately in the headline section and “possible
side effect” section of a PIL. The warning signs of addiction should be placed outstandingly as a
sub-section within the section of “possible side effects.” Better patient education is meaningful for
English university students since most of them are unfamiliar with codeine, which would help reduce
the chances of unintentional codeine misuse.
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